Dezembro 2013 vol. 1 num. 2 - Brazilian Meeting on Organic Synthesis 2013

Abstract - Open Access.

Idioma principal

Synthesis of news furo[2,3-d] pyrimidine derivatives as potential inhibitors of DHFR

Ferreira, Marcelle de Souza ; Villar, José Daniel Figueroa ;

Abstract:

Heterocyclic compounds are promising agents in the development of synthetic molecules with bioactivity. Fused heterocyclic structures containing pyrimidine or furan rings exhibited diverse biological activities such as antimicrobial, anti-inflammatory, antiviral and anticancer. The furo[2,3-d]pyrimidines, which are an important class of heterocyclic compounds, have been considered for many years as a model for the discovery of drugs for inhibition of the enzyme dihydrofolate reductase (DHFR). In view of this biological activity, the objective of this work consists on the synthesis of new furo[2,3- d]pyrimidines as potential agents to act as antifolates inhibiting DHFR, which is present in various fungi, bacteria and protozoa. These compounds may be new agents for neglected diseases.

Abstract:

Download (PDF)

Palavras-chave: benzylidene barbiturate, furo[2,3-d]pyrimidine, DHFR,

Palavras-chave:

DOI: 10.5151/chempro-15bmos-BMOS2013_2013913121221

Referências bibliográficas
  • [1] 1 Maghsoodlou, M.T.; et col. Mol. Divers. 2011, 15, 227.
  • [2] 2 Gangjee, A.; et col. Bioorg. Med. Chem. 2009, 17, 7324.
  • [3] 3 Figueroa-Villar, J.D.; et col. Heterocycles 1992, 34, 891.
  • [4] 4 Figueroa-Villar, J.D.; et col. J. Mol. Struct. 2013, 134, 310.
Como citar:

Ferreira, Marcelle de Souza; Villar, José Daniel Figueroa; "Synthesis of news furo[2,3-d] pyrimidine derivatives as potential inhibitors of DHFR", p. 224 . In: In Blucher Chemistry Proceedings, São Paulo, v. 1, n. 2, Dezembro.2013. São Paulo: Blucher, 2013.
ISSN 2318-4043, DOI 10.5151/chempro-15bmos-BMOS2013_2013913121221

últimos 30 dias | último ano | desde a publicação


downloads


visualizações


indexações